Mode
Text Size
Log in / Sign up

Mini review on fluorescence-guided imaging with indocyanine green for gallstone disease

Mini review on fluorescence-guided imaging with indocyanine green for gallstone disease
Photo by Trust "Tru" Katsande / Unsplash
Key Takeaway
Consider fluorescence-guided imaging with ICG as a potential adjunct, but recognize evidence remains preliminary.

This is a mini review that synthesizes evidence on fluorescence-guided imaging with indocyanine green (ICG) versus white light for symptomatic gallstone disease in elective and acute care settings. The authors report that ICG may improve visualization of key biliary structures and suggest potential reductions in complications, conversion to open surgery, and operative time. No pooled effect sizes, absolute numbers, or statistical measures are provided, as the evidence is qualitative.

The review notes several limitations, including heterogeneity in dosing protocols, interference from hepatic background fluorescence, and reliance on specialized imaging equipment. The authors acknowledge that the place of this technology in routine surgical practice is not established.

Practice relevance is described as a pragmatic, radiation-free modality that extends the surgeon's visual capabilities. However, the authors caution against overstating clinical benefits and the technology's role in routine practice. The review does not report specific study populations, sample sizes, or adverse events.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
Laparoscopic cholecystectomy (LC) remains the standard treatment for symptomatic gallstone disease, yet bile duct injury persists as a serious and feared complication, predominantly caused by misidentification of biliary anatomy. Fluorescence-guided imaging with indocyanine green (ICG) has gained prominence as an adjunct to enhance real-time anatomical interpretation and strengthen intraoperative safety. This mini review synthesizes current evidence supporting fluorescent cholangiography in both elective and acute care settings, where inflammation, distorted anatomy, and urgent decision-making heighten surgical risk. The manuscript provides an updated overview of the technical foundations of ICG fluorescence, practical considerations for its administration, and its incorporation into modern surgical workflows. It compiles data demonstrating improved visualization of key biliary structures, and potential reductions in complications, conversion to open surgery, and operative time. The review also addresses persistent limitations, such as heterogeneity in dosing protocols, interference from hepatic background fluorescence, and reliance on specialized imaging equipment, that continue to impede universal standardization. Taken together, these findings position fluorescence imaging as a pragmatic, radiation-free modality that extends the surgeon's visual capabilities “beyond white light,” contributing to safer and more precise LC. Ongoing technological refinement and well-designed multicenter studies will be crucial to confirm its clinical benefits and define its place in routine surgical practice.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.